You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 1384 Novel, immune agonistic CEACAM1/5 antibody (YB-200) demonstrates anti-tumor efficacy and significantly increases B-cell response in syngeneic liver Hepa1-6 tumor microenvironment

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1384 Novel, immune agonistic CEACAM1/5 antibody (YB-200) demonstrates anti-tumor efficacy and significantly increases B-cell response in syngeneic liver Hepa1-6 tumor microenvironment
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to March 2024

AbstractFullPdf
Nov 2022154019
Dec 20224608
Jan 202392012
Feb 202310607
Mar 2023180025
Apr 20234403
May 20235008
Jun 20235004
Jul 202382014
Aug 20231404
Sep 20232807
Oct 202382015
Nov 20234204
Dec 20235406
Jan 20244202
Feb 20244406
Mar 20245606
Total11660150